Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by Boomskidon Jun 30, 2023 3:06pm
137 Views
Post# 35522782

RE:RE:RE:Johnny boy

RE:RE:RE:Johnny boy

StoxComm was not designed for payment. It was a place for longer-form research and opinion. The idea was to have them archived in a place where they wouldn't be buried by ad hominem and personal attacks from trolls like you. I stopped doing serious studies about the immune system, mabs, the BBB and xB3 competotors twp or three years ago. Most shareholders were not interested.

And, yes, people called me to get information. Even Bioasis told people to ask me their questions. Carlson never did any of that work. He doesn't know anything about Bioasis except what the CEO told him.

I couldn't care less about Daniel Carlson, and his Tailwinds Research Group, DFC Advisory Services LLC, and TW Research Group LLC. Never think of him.

Funny how much he thinks about me, though. Why else would he make personal attacks about me and has done so for 2 or 3 years? A big part of his BTI posting record is about me.

Carlson acts like you and burp do. It always sounds like you're about to detonate and all I have to do is push a little spark your way and off you go.

Ok. 5 minutes. That's enough time for you today, P&H guy..

jd

 

<< Previous
Bullboard Posts
Next >>